The Million Dollar Bench: Why Building Your Own Biotech Lab Costs More Than Money—and What To Do Instead

by DAVID.KIEWLICH | Aug 14, 2026 | Biotech

So you’ve got the science down, the vision nailed, and the pitch deck perfected. But what’s stopping you from running your first experiment? It might just be one big, expensive hurdle: a lab. You need a full-on wet lab, complete with biosafety cabinets, CO2...

The Biotech Diversity Gap Is Real. Here’s How One Nonprofit Incubator Is Closing It.

by DAVID.KIEWLICH | Aug 13, 2026 | Biotech

Biotech is the cutting edge of human advancement. Gene therapies are curing rare diseases. Cell-based immunotherapies are redefining oncology. Carbon-capturing biology and engineered materials are shaping climate change. The research has never been more exciting. Yet...

Succeed or Learn, There Is No Fail: The Radical Mindset Behind a 95% Biotech Success Rate

by DAVID.KIEWLICH | Aug 7, 2026 | Biotech

Nearly 90% of biotech startups fail. This number is so ingrained in biotech that almost everyone treats it as a given. But maybe we are looking at things backwards. What if failing wasn’t the opposite of success, but what you needed to get there? At BADASS Labs, our...

No Equity, No Excuses: Why The Nonprofit Biotech Incubator Wins

by DAVID.KIEWLICH | Aug 6, 2026 | Incubator

Let’s talk about a number that haunts every biotech startup founder: 10%. Many incubators and accelerators take 10% equity for providing lab space, mentorship and connections. Ten percent of your future funding, your future milestones, your future exit, gone before...

The De-Risking Playbook: How BADASS Labs Helps Biotech Startups Build the Data VCs Demand in 2026

by DAVID.KIEWLICH | Jul 30, 2026 | Biotech

Let’s be blunt: biotech funding in 2026 is not about great science anymore. It is about proven science. Venture capitalists are actively seeking out biotechs with existing data sets and de-risked pipelines; the days of backing a tantalizing hypothesis and a...